PT1586314E - Composição de comprimidos de nateglinida - Google Patents

Composição de comprimidos de nateglinida Download PDF

Info

Publication number
PT1586314E
PT1586314E PT05014497T PT05014497T PT1586314E PT 1586314 E PT1586314 E PT 1586314E PT 05014497 T PT05014497 T PT 05014497T PT 05014497 T PT05014497 T PT 05014497T PT 1586314 E PT1586314 E PT 1586314E
Authority
PT
Portugal
Prior art keywords
tablet composition
meals
carboxymethyl cellulose
nateglinide tablet
nateglinide
Prior art date
Application number
PT05014497T
Other languages
English (en)
Inventor
Masato Kaida
Takahiko Ando
Nobutaka Ninomiya
Masanao Ozaki
Akira Yabuki
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18100283&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1586314(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of PT1586314E publication Critical patent/PT1586314E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PT05014497T 1996-11-15 1997-11-14 Composição de comprimidos de nateglinida PT1586314E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31854196 1996-11-15

Publications (1)

Publication Number Publication Date
PT1586314E true PT1586314E (pt) 2011-07-01

Family

ID=18100283

Family Applications (2)

Application Number Title Priority Date Filing Date
PT97912459T PT965339E (pt) 1996-11-15 1997-11-14 Composicao de nateglinida em comprimidos
PT05014497T PT1586314E (pt) 1996-11-15 1997-11-14 Composição de comprimidos de nateglinida

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT97912459T PT965339E (pt) 1996-11-15 1997-11-14 Composicao de nateglinida em comprimidos

Country Status (14)

Country Link
US (4) US6143323A (pt)
EP (3) EP1586314B1 (pt)
JP (1) JP4171091B2 (pt)
KR (1) KR100343062B1 (pt)
CN (1) CN1245158C (pt)
AT (2) ATE503472T1 (pt)
AU (1) AU718350B2 (pt)
CA (1) CA2271865C (pt)
DE (2) DE69735644T2 (pt)
DK (1) DK1586314T3 (pt)
ES (2) ES2257772T3 (pt)
PT (2) PT965339E (pt)
TW (1) TW492878B (pt)
WO (1) WO1998022105A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718350B2 (en) * 1996-11-15 2000-04-13 Ajinomoto Co., Inc. Tablet composition
DK2263660T3 (en) 1998-05-18 2018-01-02 Takeda Pharmaceuticals Co Orally disintegrating tablets.
ATE291418T1 (de) * 1998-07-28 2005-04-15 Takeda Pharmaceutical Leicht zerfallende feste zubereitung
JP2000119160A (ja) * 1998-10-06 2000-04-25 Kanebo Ltd 皮膚化粧料
US6878749B2 (en) 1999-09-17 2005-04-12 Novartis Ag Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
AR028299A1 (es) * 1999-09-17 2003-05-07 Novartis Ag Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
US6559188B1 (en) 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
CZ20022294A3 (cs) * 1999-12-28 2002-11-13 Ajinomoto Co., Inc. Antidiabetický preparát k orálnímu uľití
KR20070104953A (ko) * 2000-03-17 2007-10-29 아지노모토 가부시키가이샤 신경 장애용 약제
PT1334962E (pt) 2000-10-18 2007-10-09 Ajinomoto Kk ''processo de preparação de acilfenilalaninas''
CA2425538C (en) * 2000-10-18 2010-10-12 Ajinomoto Co., Inc. Methods for producing nateglinide crystals
CA2426745C (en) * 2000-10-24 2009-09-15 Ajinomoto Co., Inc. Methods for producing nateglinide b-type crystals
RU2271805C2 (ru) 2000-10-24 2006-03-20 Адзиномото Ко., Инк. Препарат, содержащий натеглинид
ATE429217T1 (de) * 2000-10-24 2009-05-15 Ajinomoto Kk Nateglinid enthaltende hydrophile arzneimittelpräparate
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
JP2003252749A (ja) * 2002-03-04 2003-09-10 Shin Etsu Chem Co Ltd 外用基剤
US6830759B2 (en) 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
CN1247194C (zh) * 2002-08-27 2006-03-29 石药集团中奇制药技术（石家庄）有限公司 一种那格列奈包合物
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
KR100882156B1 (ko) * 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 나테글리니드 함유 제제
WO2005016315A1 (en) * 2003-08-14 2005-02-24 Ranbaxy Laboratories Limited Pharmaceutical compositions of nateglinide and a high amount of a water-soluble filler
WO2005094812A1 (ja) * 2004-04-01 2005-10-13 Ajinomoto Co., Inc. ナテグリニド含有製剤
WO2005117840A1 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising pulverized granules of nateglinide of form b
WO2006013444A1 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation
JP2008509144A (ja) * 2004-08-04 2008-03-27 アルザ・コーポレーシヨン 上昇するゼロ次放出パターンを示す持続薬剤放出組成物、そのような組成物を製造する方法
CN101031322A (zh) * 2004-10-01 2007-09-05 日本脏器制药株式会社 固体药物制剂
US7276198B2 (en) * 2004-12-28 2007-10-02 The Goodyear Tire & Rubber Company Method and mold for making tire with tie bar
EP1891971A4 (en) * 2005-01-31 2010-02-03 Ajinomoto Kk MEDICAL COMPOSITION USING HYPERGLY CRAB MEDICAMENT TO TREAT OR TREAT GLUCOSE-INTOLERANCE, BORDERLINE DIABETES, INSULIN RESISTANCE AND HYPERINSULINEMIA
WO2008072534A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited マンニトール又は乳糖を含有する固形製剤
EP2100607A4 (en) * 2006-12-07 2010-01-06 Daiichi Sankyo Co Ltd COATING COMPOSITION WITH IMPROVED DURABILITY
JP5274261B2 (ja) * 2006-12-07 2013-08-28 第一三共株式会社 低置換度ヒドロキシプロピルセルロースを含有する医薬組成物
TWI405591B (zh) * 2006-12-07 2013-08-21 Daiichi Sankyo Co Ltd 固形製劑之製造方法
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
DE10199058I2 (de) 1991-07-30 2006-04-27 Alcm Co Kristalle von N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanin und Verfahren zu ihrer Herstellung
CA2123677A1 (en) * 1991-11-26 1993-06-10 Issac Ghebre-Sellassie Process and composition for the development of controlled release gemfibrozil dosage form
AU718350B2 (en) * 1996-11-15 2000-04-13 Ajinomoto Co., Inc. Tablet composition

Also Published As

Publication number Publication date
US20030147951A1 (en) 2003-08-07
CA2271865C (en) 2003-10-14
JPH10194969A (ja) 1998-07-28
AU4965497A (en) 1998-06-10
DE69735644T2 (de) 2007-05-03
ES2364145T3 (es) 2011-08-25
CA2271865A1 (en) 1998-05-28
EP0965339B1 (en) 2006-04-05
EP1586314B1 (en) 2011-03-30
DE69740161D1 (de) 2011-05-12
CN1242704A (zh) 2000-01-26
EP1586314A1 (en) 2005-10-19
DK1586314T3 (da) 2011-06-20
ES2257772T3 (es) 2006-08-01
ATE503472T1 (de) 2011-04-15
EP0965339A1 (en) 1999-12-22
EP2277517A1 (en) 2011-01-26
JP4171091B2 (ja) 2008-10-22
DE69735644D1 (de) 2006-05-18
US6641841B2 (en) 2003-11-04
ATE322260T1 (de) 2006-04-15
EP0965339A4 (en) 2003-04-23
KR20000053312A (ko) 2000-08-25
WO1998022105A1 (en) 1998-05-28
TW492878B (en) 2002-07-01
US6844008B2 (en) 2005-01-18
PT965339E (pt) 2006-06-30
US6296872B1 (en) 2001-10-02
CN1245158C (zh) 2006-03-15
US6143323A (en) 2000-11-07
KR100343062B1 (ko) 2002-07-02
AU718350B2 (en) 2000-04-13
US20020028239A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
PT1586314E (pt) Composição de comprimidos de nateglinida
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
BG102744A (bg) Дозирана лекарствена форма на ибупрофен
KR880010764A (ko) 과콜레스테롤혈중 치료용 혼합물
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
MY118164A (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
IL82209A0 (en) Insulin preparation
DK420385D0 (da) Antioestrogent laegemiddel til perkutan indgift
BR0109336A (pt) Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
NO870772L (no) Vevplasminogenaktivator for normale humane tykktarmceller.
HU912431D0 (en) Process for the production of medical preparations with sucralfat content
CA2290482A1 (en) Fructan containing composition for the prevention and treatment of colon cancer
AU6432899A (en) Use of metformin to counteract weight gain associated with valproate and other psychotropic medications
US6683098B1 (en) Use of drug miglitol (Glyset) for treatment of obesity to prevent weight gain for losing weight and for weight control
JPS6466125A (en) Remedy for gastritis
CA1179267A (en) Composition for relieving toothache pain
JPS54148090A (en) Peroral cholesterol-depressant
RU94030887A (ru) N-ацетил-дегидрофенилаланил-l-метионин
KR20040006092A (ko) 진주가루를 함유하는 아름다운 피부촉진제
蕭裕明 et al. Surgical Correction of Pes Cavus and Equinus Deformity in Two Young Adults
GR950100315A (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε εναιωρημα εμβρυικων κυτταρων με ανοσοδιορθωτικη δραση και μεθοδος θεραπειας ζαχαρωδους διαβητη με τη χρηση αυτου του παρασκευασματος.
Panthesine L-Dopa See Levodopa.
MX9603241A (es) Productos farmaceuticos para curar enfermedades tumorales y procedimiento para su preparacion.
LT2000063A (en) Food additive